Douglas B. Given, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 875 shares at $32.62 ($29K) on 2023-02-27, disclosed to the SEC on 2023-03-01.
Open-market sale of $29k ARWR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ARWR | SELL | 2023-05-08 | $266K | — | Filing → |
| ARWR | BUY | 2021-12-29 | $43K | — | Filing → |
| ARWR | SELL | 2021-09-10 | $326K | — | Filing → |